1. TY-PAN-0597(14) Date of preparation: July 2014 FOR HEALTHCARE PROFESSIONALS ONLY TYSABRI (natalizumab) Benefit/Risk Update & PML Risk Stratification 2. TY-PAN-0597(14)…
Synergistic action between viral and environmental factors in the process of malignant transformation Shih-Chao Lin Advisor: Dr. Krzysztof Reiss Human Polyomavirus JC (JCV)…